Contact Us
TEL: +86-0571-88334626
Home > News > Content
Bendamustine Market
Dec 11, 2018

Bendamustine hydrochloride, as a new generation of anticancer drugs, has obvious therapeutic effects on various cancers. Clinical application shows that this product alone or in combination with non-Hodgkin's lymphoma, multiple myeloma, CLL and breast cancer, the curative effect is clear, the recurrence rate and mortality are significantly reduced, and the adverse reactions are small and the safety is good. Ribomustin is currently priced at 25mg48.96 euros/piece in Europe and 100mg 201.45 euros/piece. Bendamustine hydrochloride for injection is safe and effective, convenient to use, rapid onset, long lasting, and can reduce costs and reduce drug prices, which will have a good market prospect and profit margin.